Evidence map›Paper›PMID 35465376›Full record

ArticleThe Pan African medical journal2022

Prevalence and factors associated with COVID-19 vaccine acceptance in Zambia: a web-based cross-sectional study.

Steward Mudenda, Christabel Nang'andu Hikaambo, Victor Daka, Misheck Chileshe, Ruth Lindizyani Mfune, Martin Kampamba, Maisa Kasanga, Margaret Phiri, Webrod Mufwambi, Michelo Banda and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Awareness and acceptance of COVID-19 vaccines and associated factors among pharmacy students in Zambia.Malawi medical journal : the journal of Medical Association of Malawi · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Steward MudendaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Christabel Nang'andu HikaamboDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Victor DakaDepartment of Public Health, Michael Chilufya Sata School of Medicine, Copperbelt University, P.O Box 71191, Ndola, Zambia.
Misheck ChilesheMaryBegg Health Services, 56 Chintu Avenue, Northrise, P.O Box 72221, Ndola, Zambia.
Ruth Lindizyani MfuneDepartment of Public Health, Michael Chilufya Sata School of Medicine, Copperbelt University, P.O Box 71191, Ndola, Zambia.
Martin KampambaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Maisa KasangaCollege of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.
Margaret PhiriSchool of Medicine and Health Sciences, Mulungushi University, P.O Box 80415 Kabwe, Zambia.
Webrod MufwambiDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Michelo BandaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Maureen Nkandu PhiriDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Moses MukoshaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
University of Zambia · ZM

Funding

The UNC-UNZA-Wits Partnership for HIV and Women's Reproductive HealthD43TW010558 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHI, BENJAMIN H., CHIBWESHA, CARLA J · 2017 to 2021
$1.5M
FIC NIH HHS D43 TW010558
6 · The paper itself

Abstract

Introduction: vaccinations against COVID-19 have been instituted to contain the pandemic. However, information about the acceptability of COVID-19 vaccines in Zambia is lacking. Therefore, the study assessed the prevalence and factors associated with COVID-19 vaccine acceptance among the general population in Zambia. Methods: this was an online questionnaire-based cross-sectional study conducted from 13 Results: of the 677 participants, only 33.4% (n = 226) would accept the vaccine if made available to them. In multivariable regression analysis, respondents who were older than 41 years compared to the 18 to 23 years age group (aOR: 2.77, 95% CI: 1.03-7.48), those who agreed (aOR; 22.85, 95% CI: 11.49-45.49) or did not know (aOR; 3.73, 95% CI: 2.29-6.07) compared to those who disagreed that the COVID-19 vaccine passed through all the necessary stages to ensure its safety and effectiveness, and those who were aware (aOR; 11.13, 95% CI: 5.31-23.35) compared to those who were not aware that the COVID-19 vaccine reduces virus transmission, were more likely to accept the vaccine. Conversely, entrepreneurs compared to government employees (aOR; 0.24, 95% CI: 0.07-0.79) were less likely to accept vaccination. Conclusion: awareness of the COVID-19 vaccine was high despite low acceptability levels. These findings are significant as they highlight the need to develop strategies for improving vaccine acceptability in Zambia.

Indexed as

COVID-19VaccinesAdultCOVID-19 VaccinesCross-Sectional StudiesHumansInternetPrevalenceSARS-CoV-2VaccinationZambiaCOVID-19 VaccinesVaccinesCOVID-19 vaccinepandemicvaccinationvaccine acceptability

Identifiers

PMID35465376
PMCPMC8994469
OpenAlexW4210934046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.